We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed patients with shoulder ...
Objectives To assess the long-term efficacy of arthroscopic subacromial decompression (ASD) by comparing it with diagnostic arthroscopy (primary comparison), a placebo surgical intervention, and with ...
POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...
Objective To determine the benefits and harms of subacromial decompression surgery in adult patients with subacromial pain syndrome lasting for more than 3 months. Design Systematic review with ...
Mika Paavola, Antti Malmivaara, Simo Taimela, Kari Kanto, Jari Inkinen, Juha Kalske, Ilkka Sinisaari, Vesa Savolainen, Jonas Ranstam, Teppo L N Järvinen and Finnish Shoulder Impingement Arthroscopy ...
Innocoll Pharmaceuticals Limited, a commercial-stage biotechnology company and portfolio business of Gurnet Point Capital, and DURECT Corporation announced the recent commercial launch of Posimir ...
Please provide your email address to receive an email when new articles are posted on . Results showed a subacromial balloon spacer provided early functional recovery and pain relief with shorter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback